In the News

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient demographics.  The research effort seeks to better understand...

Emerging Leaders 2024: Carrie Williams, McKesson Ventures

McKesson Ventures Vice President and Partner Carrie (Hurwitz) Williams was named as one of Global Corporate Venturing (GCV)’s top “Emerging Leaders for 2024”! Announced on Monday, March 11th, Williams was praised by GCV for her experience with “the business development side of corporate venturing, helping...

Forbes’ 2024 List of America’s Best Startup Employers

McKesson Ventures portfolio companies Aledade Inc, Lightship, and Xealth were recently named among Forbes magazine’s list of America’s Best Startup Employers. Forbes partnered with third-party research firm Statista to assess over 3,000 companies, primarily examining their reputation, employee satisfaction, and growth. Each company assessed had...

PM360 Announces the Selections for its 12th Annual Innovations Issue

On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of areas, including Artificial Intelligence, Clinical Trials, Startups, and more, and...